title: Caution should be used when interpreting alterations affecting the exon 3 of the BRCA2 gene in breast/ovarian cancer families.
authors.forename: Orland
authors.initials: O
authors.lastname: Díez
authors.forename: Sara
authors.initials: S
authors.lastname: Gutiérrez-Enríquez
authors.forename: Teresa
authors.initials: T
authors.lastname: Ramón y Cajal
authors.forename: Carmen
authors.initials: C
authors.lastname: Alonso
authors.forename: Judith
authors.initials: J
authors.lastname: Balmaña
authors.forename: Gemma
authors.initials: G
authors.lastname: Llort
mesh_terms: D000328:Adult; D001943:Breast Neoplasms / Q000235:genetics*; D005091:Exons / Q000235:genetics*; D005260:Female; D024522:Genes, BRCA2; D005817:Genetic Counseling; D005820:Genetic Testing; D006258:Head and Neck Neoplasms / Q000235:genetics; D006801:Humans; D054643:INDEL Mutation; D008297:Male; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000235:genetics*